0

Ki 16425

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP355025240
CAS355025-24-0
Molecular Weight474.96
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Evidence for Lysophosphatidic Acid 1 Receptor Signaling in the Early Phase of Neuropathic Pain Mechanisms in Experiments Using Ki-16425, a Lysophosphatidic Acid 1 Receptor Antagonist

Lin Ma, Misaki Matsumoto, Weijiao Xie, Makoto Inoue, Hiroshi Ueda

J Neurochem. 2009 Apr;109(2):603-10.

PMID: 19222705

1

Involvement of Lysophosphatidic Acid-Induced Astrocyte Activation Underlying the Maintenance of Partial Sciatic Nerve Injury-Induced Neuropathic Pain

Hiroshi Ueda, Hiroyuki Neyama, Jun Nagai, Yosuke Matsushita, Tamotsu Tsukahara, Ryoko Tsukahara

Pain. 2018 Nov;159(11):2170-2178.

PMID: 29939962

1

Lysophosphatidic Acid LPA

Hiroshi Ueda, Hiroyuki Neyama, Keita Sasaki, Chiho Miyama, Ryusei Iwamoto

Neurobiol Pain. 2018 Jul 20;5:100020.

PMID: 31194070

1

Lysophosphatidic Acid Provides a Missing Link Between Osteoarthritis and Joint Neuropathic Pain

J J McDougall, S Albacete, N Schuelert, P G Mitchell, C Lin, J L Oskins, H H Bui, M G Chambers

Osteoarthritis Cartilage. 2017 Jun;25(6):926-934.

PMID: 27651153

1

Lysophosphatidic Acid Receptors (LPARs): Potential Targets for the Treatment of Neuropathic Pain

María Velasco, Catherine O'Sullivan, Graham K Sheridan

Neuropharmacology. 2017 Feb;113(Pt B):608-617.

PMID: 27059127

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode